These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12954888)

  • 1. Stroke: Effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations.
    Stahl JE; Furie KL; Gleason S; Gazelle GS
    Radiology; 2003 Sep; 228(3):659-68. PubMed ID: 12954888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.
    Lin CB; Peterson ED; Smith EE; Saver JL; Liang L; Xian Y; Olson DM; Shah BR; Hernandez AF; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):514-22. PubMed ID: 22787065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
    Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
    Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cuyahoga County Operation Stroke speed of emergency department evaluation and compliance with National Institutes of Neurological Disorders and Stroke time targets.
    Katzan IL; Graber TM; Furlan AJ; Sundararajan S; Sila CA; Houser G; Landis DM;
    Stroke; 2003 Apr; 34(4):994-8. PubMed ID: 12624218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital.
    Charipar R; Charipar E
    WMJ; 2008 Jul; 107(4):176-80. PubMed ID: 18702433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A regional system of stroke care provides thrombolytic outcomes comparable with the NINDS stroke trial.
    LaMonte MP; Bahouth MN; Magder LS; Alcorta RL; Bass RR; Browne BJ; Floccare DJ; Gaasch WR;
    Ann Emerg Med; 2009 Sep; 54(3):319-27. PubMed ID: 19101059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal.
    Jones ML; Holmes M
    Health Technol Assess; 2009 Sep; 13 Suppl 2():15-21. PubMed ID: 19804685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection.
    Gazelle GS; McMahon PM; Beinfeld MT; Halpern EF; Weinstein MC
    Radiology; 2004 Dec; 233(3):729-39. PubMed ID: 15564408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
    Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
    Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).
    Eissa A; Krass I; Bajorek BV
    J Clin Pharm Ther; 2012 Dec; 37(6):620-9. PubMed ID: 22708668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator.
    Abdullah AR; Smith EE; Biddinger PD; Kalenderian D; Schwamm LH
    Prehosp Emerg Care; 2008; 12(4):426-31. PubMed ID: 18924004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group.
    Fagan SC; Morgenstern LB; Petitta A; Ward RE; Tilley BC; Marler JR; Levine SR; Broderick JP; Kwiatkowski TG; Frankel M; Brott TG; Walker MD
    Neurology; 1998 Apr; 50(4):883-90. PubMed ID: 9566367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual TeleStroke support for the emergency department evaluation of acute stroke.
    Schwamm LH; Rosenthal ES; Hirshberg A; Schaefer PW; Little EA; Kvedar JC; Petkovska I; Koroshetz WJ; Levine SR
    Acad Emerg Med; 2004 Nov; 11(11):1193-7. PubMed ID: 15528584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
    Stroke; 1997 Aug; 28(8):1530-40. PubMed ID: 9259745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States.
    Demaerschalk BM; Yip TR
    Stroke; 2005 Nov; 36(11):2500-3. PubMed ID: 16224087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.